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The aim of this study was to reduce antimicrobial use (AMU) on dairy farms that
implemented evidence-based management strategies. The study not only examined
whether these strategies led to a reduction in AMU in practice, but also examined
the influence of the level of their implementation on AMU. For data analysis, practice
software recordings of the farm veterinarians were used. The AMU data of 50 farms with
prevention strategies applied (intervention group, IG) over 3 years (2017–2019) and of 74
farms without prevention strategies (control group, CG) over 2 years (2018–2019) were
analyzed. Project participation was supported with 500 Swiss francs (∼545 USD) per
farmer per year. The AMU was compared between the IG and CG using the treatment
incidence. In December 2017/January 2018, the farmers of the IG had chosen at least
one of the proposed 17 prevention strategies from one of three sectors, i.e., udder health,
uterine health and/or replacement calf health. The prevention strategies, were developed
in a standard operating procedure protocol and were discussed in detail with the farmers
before the implementation. Forty-eight farms chose at least one udder strategy, 10
farms at least one uterine strategy and 37 farms at least one calf strategy. By choosing
an udder health strategy or a uterine health strategy, the corresponding systemically
administered AMU could be significantly reduced (p < 0.04) in the IG compared with the
CG. In addition, udder strategies that were well-implemented led to a significant reduction
(p = 0.05) of intramammary “highest priority critically important antimicrobials (HPCIA)”
(quinolones, cephalosporins 3rd and higher generation, macrolides and ketolides,
glycopeptides, and polymyxins). The level of implementation was significantly lower in
2019 compared to 2018 (p < 0.05, Fisher’s exact test). No significant reduction in AMU
could be achieved for the calf sector. A reduction of AMU in dairy farms is possible
by implementing evidence-based management-related prevention strategies. The level
of implementation has only an influence on the consumption of HPCIA. The reduction
of AMU in practice by means of evidence-based measures requires supportive human
resources instead of financial support, because financial support for farmers seems not
to motivate them sufficiently.
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INTRODUCTION
The development of antimicrobial resistances in bacteria leads
to major problems in both human and veterinary medicine. The
current efforts of various institutions such as governments or the
World Health Organization aim at reducing antimicrobial use
(AMU) toward a targeted, reasonable and evidence-based AMU.
Evidence-based means adherence to a procedure, in this case the
treatment with antimicrobials (AMs), which is based on the best
and most recent scientific knowledge.
The sales of AMs in veterinary medicine in Switzerland
decreased from 76mg/PCU (population correction unit: 1 PCU
= 1 kg farm animal) in 2009 to 38 mg/PCU in 2019 (1). This
reduction was mainly due to lower sales of drug premixes. In
comparison with 30 EU countries, Switzerland ranks in 2017
the 21st among these countries, regarding AMU. However,
Switzerland ranked first for highest intramammary AM drug
user and second for intrauterine AM-containing preparations
(2). Due to the fact that these two categories are used almost
exclusively for cows and there are many more dairy cows
[522,723 in 2018 (3)] than female, adult suckler cows [14,034
cows in 2018 (4)] in Switzerland, it can be assumed that this
consumption is mainly attributable to dairy cattle.
On dairy farms, three common areas of AMU are udder
health, uterine health and replacement calf health. Udder
infection (mastitis) is one of the most common diseases in dairy
cows. In most cases mastitis is caused by a bacterial infection.
Cows with mastitis often need to be treated with AMs due to
animal welfare reasons (5). Due to the high costs (treatment
costs, decreased milk yield, milk withdrawal, premature culling),
it is often preferable to prevent and control mastitis at farm
level rather than to treat affected animals (6, 7). The incidence
of mastitis can be reduced by controlling various factors. One
of the most important factors is hygiene. Firstly, poor hygiene
of the bedding in the lying area, caused by poor care of the
bedding or heavily soiled claws and legs, increase bacterial load
and thus the risk of mastitis (8–11). Secondly, metabolic diseases
such as hypocalcemia (occurringmainly in the transition period),
which cause recumbency, increase the risk of mastitis due to the
long exposure of the teats with the bedding, contaminated with
bacteria, and due to a weakening of the teat sphinctermuscle (12).
The immune system is also significantly weakened in metabolic
diseases such as ketosis, so that the risk of mastitis increases (13,
14). Thirdly, good hygiene duringmilking, as well as correct post-
milking teat-dipping, contributes to preventing bacteria enter
the teat-canal during milking and mastitis being transmitted
between cows (15, 16). The identification of the pathogen causing
the mastitis is not only important in choosing of the active
ingredient, but also for defining the optimal moment to start the
therapy. In order to improve udder health, it is important to treat
existing mastitis caused by contagious pathogens as quickly and
efficiently as possible to keep the risk of transmission low (17).
Dairy cows developed uterine disease are often treated with
AM to prevent a decrease in milk yield and poor fertility and
reduce suffering by combining AM and pain medication (18, 19).
However, prevention of postpartum uterine diseases should be
preferred to treatment (20). Uterine health and fertility can be
significantly improved and AMU reduced (21–24) by avoiding
metabolic diseases such as hypocalcemia or ketosis, occurring
mainly in the transition period, by also improving the overall
immunity, health and environmental hygiene around calving
and in obstetrics. Bacterial infections of the uterus (endometritis
or metritis) may lead to decreased reproductive performance
(25–29) and are therefore often treated with AMs (30). Since a
retained placenta is one of the major predisposing factors for
uterine infection, it is also often treated with AMs, although it
is not an infectious disease per se (31).
In the calf sector (including veal calves and replacement
calves) most AMs are prescribed to treat respiratory and
gastrointestinal diseases (30, 32). The problem of AM resistances
is also a major issue in calf disease (33–36). In order to improve
the situation and to be able to reduce AMs while maintaining
good animal health, calf management is an important factor
together with the farmers’ mindset (37). In addition to the type of
housing and group size, the colostrum supply and administration
of trace elements, for example, are management elements that
influence the health and thus AMU of calves (38–41). Many
treatments with AMs in calves are performed without previously
consulting a veterinarian (42, 43) which may lead to untargeted
or even unnecessary use of AM.
Of course, the veterinarian also has an important role when
it comes to AMU on the farms. In Switzerland, farmers can
only obtain AMs through their veterinarian. Only if the farmers
have a defined contract with a veterinarian is it allowed to
sell AMs to the farmers for future use, so that the farmers
can initiate treatments of affected animals themselves (44).
However, dispensing stockpiled medication is prohibited as a
preventive use of AMs such as systematic drying- off in the
herd (blanket dry cow treatment). The farmer must provide
some evidence (e.g., cell count measurement of the cow or
result of a milk analysis) in order for the veterinarian to allow
the dispensing of AMs. It is completely forbidden to dispense
HPCIAs for potential future treatments. Farmers can only sign
this contract with one veterinarian at a time. The prescription
of AMs by veterinarians is influenced by various factors, for
example the knowledge and experience of the veterinarian (45–
48). There is hardly any research on this topic specifically
for Switzerland, although Carmo et al. showed a similar
tendency (49).
Although there are many studies investigating management
practices to reduce the effect of AMU, practicing veterinarians
or farmers experience difficulties in their implementation. This
is related to the fact that the research is often performed
under study conditions with the greatest caution and effort (e.g.,
supervision andmonitoring) provided for the entire study group.
In practice, however, implementing new features is not always
as easy as it seems at first sight. The translation of complex
knowledge from research into practice is also described by De
Vliegher et al. as one of the key points in the control of mastitis
(17). In addition, personality, own experiences, motivators and
knowledge of a person, in our case the farmers, influences greatly
a change in behavior (41). This rationale has been summarized
and described several times in different theories or behavioral
models (50, 51). In the study presented here, we investigated for
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the first time the implementation level of management changes
as a factor influencing AM reduction on Swiss dairy farms.
The objective of this study was to reduce AMs by
implementing a selection of evidence-based management
practices, and at the same time maintain good animal health
on the farm with a maximum deterioration of health indices
by 5%. We hypothesized that dairy farmers who implemented
management changes will achieve a greater reduction in AMU
than farmers who did not implement changes. Furthermore, we
hypothesized that the higher the level of implementation of the
prevention measures, the greater the reduction in AMU.
MATERIALS AND METHODS
Study Population
This study evaluates data from a convenience sample. In total 138
dairy farmers participating in a voluntary, regional AM reduction
project were included in this study. Sixty-four farmers chose to
participate in the intervention group (IG) from January 2017 to
December 2019 on a voluntary basis. In parallel, the remaining 74
dairy farmers served as a control group (CG) from January 2018
to December 2019.
Farmers of the IG were recruited during 2017. Veterinarians
of the IG farmers collected data on AMU and farmers collected
animal health data during 2017, serving as a reference before
the application of an intervention. The interventions were
then implemented from January 2018 to December 2019. The
participating farmers all signed a declaration of consent that
allowed the collection of treatment data of their animals from
their veterinarian. In addition, all farmers signed a contract
with the project management, in which they commit themselves
implementing the selected strategies and for which they received
financial compensation (see Antimicrobial Reduction Project).
In parallel, 74 dairy farmers (from the same region, producing
under the same conditions and supervised by the same
veterinarians as the farms in the IG) served as a control group
(CG). The farms of the CG were recruited during 2019, with the
aim of serving as intervention farms for a second phase of the
project (2020–2024). In order to be able to compare the farms
of the IG with those in the CG, the treatment data for the AMU
and the animal health data of the CG farms were retrospectively
collected from the veterinarians and the breeding associations for
the years 2018 and 2019. As there were changes of veterinarians
and some farms did not agree to analyze the data so far back, a
retrospective analysis until 2017 was unfortunately not possible.
Data of the CG were thus available for the years 2018 and 2019.
Antimicrobial Reduction Project
Veterinarians of the IG farmers collected data on AMU and
farmers collected animal health data during 2017, serving as a
reference before applying an intervention. At the end of 2017, the
intervention group selected at least one strategy of management
changes from a set of 17 evidence-based prevention strategies
(Appendix I) to be implemented in 2018 and 2019. The proposed
strategies with preventive measures to be implemented on farms
are based on current scientific knowledge and are considered
efficient in terms of improving animal health or preventing
disease. Prior to selecting the prevention strategies, each farm of
the IG was visited by a veterinarian and an animal scientist and
the problem areas of each farm were identified and discussed.
The set of preventive measures for selection consisted of
strategies concerning the following three health areas: udder
health, uterine health and calf health. All strategies aim to
improve animal health through preventive measures (strategies
1–5 and 8–17) or to use the correct AMs in the sense of a
targeted treatment (strategies 6 and 7). In brief, the strategies
for controlling mastitis included systematic bacterial culturing
of high somatic cell count and cows with clinical mastitis,
improving overall barn hygiene in order to have an improved
hygiene of the animals, improving the milking routine and
hygiene during milking and preventing milk fever and ketosis.
The strategies to prevent uterine disease included measures to
improve hygiene around calving and prevention ofmilk fever and
ketosis. Finally, themeasures for preventing calf disease consisted
of improving colostrum management, vaccination, improving
barn hygiene, improving the feeding of calves and providing
vitamins and trace elements.
Each farm was visited by the same veterinarian (MG) and by
one of three animal scientists. This ensured that the procedure
on the farms was as uniform as possible. Due to the individual
analysis of the health situation on each farm, the discussion
was, however, inevitably individual to the farm, despite the same
procedure. A veterinarian (MB), in collaboration with animal
scientists compiled the set of strategies using evidence-based
knowledge. Strategies for udder health, uterine health and calf
health were defined and elaborated and recorded in specific
protocols. Based on these protocols, the farmer who chose the
corresponding strategy was able to implement the strategy step
by step.
These consultants discussed the current situation on the farms
with the farmers, inspected the treatment journals and identified
the problem areas on the farms. Afterwards, different prevention
strategies were presented to the farmers in detail, of which they
should choose at least one. The choice of strategy was then left
exclusively to the farmers, and no recommendation was made
by the consultants regarding as to which strategies would be
preferable for their farms situation. The practical implementation
was discussed with the veterinarian and the animal scientist at the
beginning of 2018 and open questions could be clarified.
Participation in the AM reduction project was remunerated
for farmers with 500.- Swiss Francs (∼548.00 US Dollars) per
farm per year. In addition, the participants of the IG who
have chosen an udder strategy had their costs reimbursed for
the bacteriological milk analyses and resistance testing by the
project. For farmers who have chosen the colostrummanagement
strategy, a colostrometer was provided free of charge.
Data Collection
Antimicrobial Use
Farmers were recruited as study participants. The participating
farmers signed a written agreement allowing access to the
data recorded by their veterinarians. The farm veterinarians
provided treatment data on the participating farms. On request,
the veterinarians extracted the documented and invoiced
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medication used or dispensed during the study period from
their practice software. Veterinarians are not obliged to keep this
documentation, but they need it for invoicing their services to
their customers, the farmers. As mentioned in the introduction,
in Switzerland, only veterinarians who have a contract with
the farmers for the supply of veterinary medicinal products are
allowed to supply AMs without clinical consultation (44). For
each Swiss farmer it is only possible to conclude such a contract
with one veterinarian. The treatment and supply data collected
by the farm veterinarian, with whom the farmer had a contract
for supplying AMs, was chosen for each farm in our project.
During the data cleaning process, all AM treatments in dairy
cows or replacement calves and heifers with the corresponding
indication or diagnosis were extracted from the dataset received
by the veterinarians. At the same time, the AM treatments in
these datasets were classified into one of the following four
categories: “Udder Health,” “Uterine Health,” “Calf Health,” and
“Other” (e.g., claw health or digestive disorders, or drugs that
were dispensed for future use without a clear indication or
diagnosis) (Appendix II).
To classify antimicrobial agents according to their
importance, the list from the World Health Organization
(WHO) was used. In this list, fluoroquinolones and other
quinolones, 3rd and 4th generation cephalosporins, macrolides
and ketolides and glycopeptides (not approved for use in
veterinary medicine) are classified as highest priority critically
important antimicrobials (HPCIA). Alternatively, the list of the
OIE (Office International des Epizooties) or the EMA (European
Medicines Agency) were consulted, which focus more on
veterinary medicine. However, Swiss legislation defines 3rd and
4th generation cephalosporins, macrolides and fluoroquinolones
as antimicrobial agents that may not be supplied as stockpiled
medication. This legal obligation has led the authors not to
choose the OIE or EMA list, as it is less suitable for the Swiss
legal situation.
Animal Health Data
The breeding associations (Swissherdbook, Holstein Switzerland
and Braunvieh Schweiz) of the farms provided individual
somatic cell count to enable assessment of udder health of the
participating farms. The mean of the monthly yield corrected




(amount of milk x cell count)
∑
amount of milk
Based on the monthly means, the geometric mean value was then
determined over 3 months in order to obtain a quarterly value.
Furthermore, annual fertility data was determined by the
breeding associations using the “voluntary waiting period,” the
“calving to conception interval,” and the “calving interval” and
weremade available for the study. The “voluntary waiting period”
describes the time after calving until the first insemination.
The “calving to conception interval” includes the time between
calving and the successful insemination. The “calving interval”
describes the number of days between two consecutive calvings.
In Switzerland there is no standardized system for recording
cattle disease except for reportable diseases. The only way to
gather information on disease prevalence or incidence, which
are both very important as key performance indicators for
cattle health, was the recordings of the digital treatment journal
completed by farmers and was meant to serve as a database
to calculate disease incidence in the present project. However,
the review of data quality (2018) showed that data collection by
farmers only lead to incomplete and therefore not evaluable data.
Control of Strategy Implementation
For each strategy, the level of implementation was described as
“implemented,” “partially implemented,” and “not implemented.”
The implementation level of the strategies related to milk
quality (strategy 6, 7, 8), the number of milk sample results
per farm was compared to the number of cows exceeding
individual cell count of 150,000 cells per ml in the monthly
milk recording. This enabled an estimation of whether the milk
from cows that needed to be analyzed according to the chosen
strategy (Supplementary Information) were actually sampled
and analyzed, as a measurement for the level of the strategy
implementation. For strategies that result in drug applications
(strategy 13, 14 and parts of strategy 2 and 10) the sales data
of the veterinarian in relation to the number of animals in the
respective age group in the herds were used to evaluate the level of
implementation. This is possible because in Switzerland, vaccines
and drugs for injection (like selenium, vitamin D3 or iron) and
AMs are only available from the veterinarian. For strategy 1, 9
and 16 a farm visit of the veterinarian (MG) was needed to start
the implementation at all. This includes the strategies with the
BCS determination of all cows in the herd as well as the climate
measurements in the calf barn. Each of these visits with resulting
recommendations was summarized in a written report from the
veterinarian (MG) addressed to the farmers. The implementation
level of the remaining strategies (strategy 3, 4, 5, 11, 12, 15, and 17
plus parts of strategy 2 and 10) was assessed on site at least once
a year by the same observer (MG) using standardized evaluation
sheets (Appendix III). If a farm selected several strategies in the
same health sector, the best implemented strategy was used to
categorize the evaluation for the entire health sector.
Data Analysis
For the IG data from January 2017 to and including December
2019 was analyzed. For CG, the data was analyzed from January
2018 to and including December 2019.
The data cleaning, processing and calculation of treatment
incidences was done with Excel (Microsoft, 2020 Version 16.36).
Statistical analysis was performed with R (http://cran.r-project.
org, Version 3.3.0, Boston, MA, USA).
Calculation of Treatment Incidence
Treatment incidence (TI) was used as a measure in order
to quantify AMU and to be able to compare the values
internationally (5, 32, 52–56). The DDDvet (=defined daily
dose) and DCDvet (=defined course dose) values published by
EMA [224954/2016 (57)] were used to calculate this treatment
incidence. By using DDDvet and DCDvet for calculating the
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TI, the dosage recommendation for each active substance used
per animal species and application route were considered.
The DDDvet gives the daily dosage recommendation, and
the DCDvet gives the dosage recommendation for the entire
duration of therapy according to EMA guidelines.
A treatment incidence was calculated for each health
category and each quarter (Jan-March, April-June, July–Sep,
Oct–Dec for the years 2017 to 2019). TI were calculated for
all AMs as well as for the HPCIAs alone. The TI are given
in the following units: TI IMMlact = defined daily dose for
animals (DDDvet) per cow per 1,000 days, TI IMMdry =
defined course dose for animals (DCD vet) per cow per 1,000
days, TI IUute = DDDvet per cow per 1,000 days, TI SYSudd
and TI SYSute = DDDvet per cow per 1,000 days, TI for
calves = DDDvet per calf per 1,000 days. The calculation is
based on a standard weight of 600 kg for cows and 80 kg for
replacement calves (58, 59). The TI are calculated as follows:
TI “IMMlact” =
Amount of used udder injectors
DDDvet [per teat] x number of days x number of animals
× 1000
TI “IMMdry” =
Amount of used udder injectors










x number of days x number of animals x standard weight cow(600kg)
× 1000
TI “IUute” =
Amount of used uterine tabs
DDDvet [intruterine product per animal] x number of days x number of animals
× 1000
TI “CALFtot” =




x number of days x number of animals x standard weight calf (80kg)
× 1000
The number of cows and calves per farm was recorded by
the breeding associations quarterly. To calculate TI CALF the
number of animals younger than 7 months were counted. For
all the other TIs the number of cows, defined as animals with at
least one calving, were counted. This data was calculated by the
breeding associations for each quarter.
Treatment data of heifers was not included at all and was also
not counted for the number of animals. The exact number of days
at risk (number of days per quarter) was used for the calculation
of each TI.
Statistical Analysis
For the data evaluation, the sample sizes per strategy are too small
for an individual evaluation of each strategy. For this reason, all
strategies were allocated to the three health sectors, i.e., udder
health (strategies 1–8), uterine health (strategies 9–11) and calf
health (strategies 12–17) and the following analyses were carried
out at this level.
Firstly, a descriptive analysis of the data was carried out to
compare the study populations of the IG and CG. Non-normally
distributed continuous and categorical data of two groups
were compared by the Wilcoxon-rank-sum test. Comparison of
categorical data was done by the Chisquare test. Secondly, to
compare AMU between IG and CG at the beginning of the
intervention, the 5th quarter (January to March 2018) of both
groups was used, as this is the earliest quarter for which data
was collected from both groups. The distribution of the TI was
visually explored by histogram and statistically by the Shapiro-
Wilk test.
Two types of mixed effect zero-inflated nested models were
applied. In the first type of models it was investigated whether
strategy selection had any influence on the TI, by comparing
the CG farms with the IG farms. The TI (from January 2018 to
December 2019) of the farms from the IG, whose farmers have
chosen at least one strategy from the sector under investigation,
was compared with the farms from the CG. The TI was used as
the outcome and the number of prevention strategies selected
was used as an independent fixed effect. The second type of
models was applied to investigate the influence of the level of
intervention implementation on the TI. Here, the TI (January
2017–December 2019) of IG farms, whose farmers had chosen a
prevention strategy and implemented it with different quality was
compared with farms from the IG whose farmers had not chosen
a strategy in this area. The independent fixed effect variable
was therefore the level of implementation, while 0 stands for
farmers not chosen a strategy, and 1–3 for farmers that have
chosen a strategy with different levels of implementation (1 =
implemented, 2= partially implemented, 3= not implemented).
For both model types, farms nested within quarters were used
as random-effects in the models. The glmmTMB package in R
for zero-inflated generalized linear mixed models was used for
the analysis. In case of large enough sample size each model
has been tested for region, breed and herd size by taking these
variables into account as additional fixed effects. The model with
the lowest AIC has been considered as the final model. For the
zero-inflated parameter, depending on whether the zeros were
equally distributed between the fixed effect levels, ziformula =
1 or ziformula = independent fixed effect was applied (60).
Different distributions of the outcome variable (TI) were tested
and the best fitting models, based on the Akaike information
criterion (AIC), were used.
The level of significance was set at p ≤ 0.05.
RESULTS
Treatment and health data from 124 farms (IG n = 50, CG
n= 74) provided by the veterinarian and the breeding association
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Number of farms 50 74
Average herd size
-Number of cows with at least
one calving
45.8 (SD 26.1) 37.0 (SD 21.9)
-Number of replacement calves
(younger than 7 months)
15.9 (SD 9.7) 12.9 (SD 7.4)
Average milk yield (kg/year/cow) 8,542 (SD 88.3) 8,062 (SD 876.3)
Cow breed
Dairy breed farms* 43 (86%) 45 (60.8%)
Dual purpose breed farms** 3 (6.0%) 14 (18.9%)
Number of farms with a
combination of breeds
4 (8.0%) 15 (20.3%)
Region of the farm
Valley region farms 20 (40%) 28 (37.9%)
Hill region farms 13 (26% 24 (32.4%)
Mountain region farms 17 (34%) 34 (29.7%)
Number of different veterinarians
Number of different veterinarians/
veterinary practices
12 14






*Dairy breeds = Holstein Friesian, Red Holstein, Jersey, Brown Swiss.
**Dual purpose breeds = Simmental, Swiss Fleckvieh, Montbéliard, Braunvieh,
Original Braunvieh.
were evaluated. The data of 14 farms was not included at all
because of following reasons: cancellation due to time constraints
during the project period (n = 7), cancellation due to health
reason of the farmer during the project period (n = 1), and no
health data available from the veterinarian (n = 6). The last 6
months of the project period (July–December 2019) were not
evaluated by two farmers, as one of them had quit the project in
September 2019 and one hadmademassivemanagement changes
on the farm (merging of two herds in a new barn).
Study Population
The different farm characteristics such as herd size, breed, milk
yield, region, and number of different veterinarians per group are
listed in Table 1.
The breeds of the study population differed significantly
between the IG and the CG (p < 0.05, Pearson’s Chi-square test).
The region distribution between the IG and CG do not differ
significantly (p > 0.05, Pearson’s Chi-square test). The herd size
regarding adult cattle differed significantly between IG and CG
(p < 0.05, Wilcox rank sum test). The average milk yield per
cow per year per farm from 2017 to 2019 differed significantly
between the two groups (p < 0.05, Wilcox rank sum test). The
remaining farm characteristics do not differ significantly between
the two groups.
Choice of Prevention Strategies
In 48 out of 50 IG farms, farmers chose strategies to improve
udder health 114 times. Strategies to improve uterine health were
TABLE 2 | Number of farmers who chose a strategy.
Udder health Topic Number of
farmers
Strategy 1 Strengthening of the immune system 16
Strategy 2 Prevention of concomitant diseases (like milk fever) 11
Strategy 3 Hygiene of the lying surface 4
Strategy 4 Hygiene of the alleys 3
Strategy 5 Reduction of infections during milking 6
Strategy 6 Control plan for subclinical mastitis 29
Strategy 7 Treatment of clinical mastitis without fever 13
Strategy 8 Treatment for drying off 32
Uterine health
Strategy 9 Strengthening of the immune system 7
Strategy 10 Prevention of concomitant diseases (like retained
placenta)
4
Strategy 11 Reduction of microbial pressure at birth 1
Calf health
Strategy 12 Colostrum management 11
Strategy 13 Administration of essential elements 19
Strategy 14 Vaccination 14
Strategy 15 Calf housing 7
Strategy 16 Calf keeping and stable climate 9
Strategy 17 Calf feeding 4
chosen 12 times by 10 different farmers. Thirty seven different
farmers selected 64 strategies related to improving calf health.
Table 2 shows which strategy has been selected by how many
farmers. The three most chosen strategies are strategy 6 (n = 29)
and 8 (n = 32) out of the udder health sector and strategy 13
(n= 19) out of the calf health sector.
Level of Implementation of Prevention
Strategies
The level of implementation was significantly inferior in 2019
compared to 2018 (p < 0.05, Fisher’s exact test). Table 3 shows
the classification of the implementation level of health sector by
each farmer.
Use of Antimicrobials
The TI of the 5th quarter between the IG and CG did not differ
significantly (p > 0.05, Wilcoxon rank sum test), except for the
use of HPCIAs in the two subcategories SYSudd and SYSute
(p < 0.05, Wilcoxon rank sum test), in which the use was higher
in the IG. This indicated that at the beginning of the intervention,
when we do not yet expect the intervention to influence the TI,
the AMU is comparable between the two groups.
Table 4 shows the descriptive statistics of TI per health
sector and (if applicable) per administration route. This
table contains all farms of the respective group, independent
of the number of strategies implemented and the level of
implementation, respectively. When investigating those two
effects [number of strategies implemented (model 1) and the level
of implementation (model 2)], most of the TI categories did not
change significantly (Table 5). For somemodels the region, breed
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The level of implementation was divided into “implemented”, “partially implemented” and “not implemented”.
TABLE 4 | Treatment incidence per group (median, interquartile range, 2.5th percentile, 97.5th percentile) of antimicrobials for the intervention group and the
control group.













IMMlact IG 6.35 10.24 0.00 39.34 4.21 9.95 0.00 30.65 7.37 10.36 0.00 40.35
DDD per cow per 1,000 days CG 5.95 10.70 0.00 37.04 6.21 10.17 0.00 32.09
IMMlact HPCIA IG 0.00 0.65 0.00 10.00 0.00 0.00 0.00 5.88 0.00 0.57 0.00 7.22
DDD per cow per 1,000 days CG 0.00 0.00 0.00 6.80 0.00 0.00 0.00 7.92
IMMdry IG 0.32 1.38 0.00 4.68 0.34 1.19 0.00 3.47 0.50 1.46 0.00 4.50
DCD per cow per 1,000 days CG 0.33 1.36 0.00 5.07 0.45 1.57 0.00 4.64
SYSudd IG 0.48 1.88 0.00 9.24 0.55 1.97 0.00 9.26 0.85 1.92 0.00 6.47
DDD per cow per 1,000 days CG 0.14 2.04 0.00 7.64 0.17 2.02 0.00 6.23
SYSudd HPCIA IG 0.00 0.04 0.00 3.07 0.00 0.00 0.00 3.40 0.00 0.06 0.00 2.21
DDD per cow per 1,000 days CG 0.00 0.00 0.00 2.91 0.00 0.00 0.00 1.64
SYSute IG 0.00 0.47 0.00 1.51 0.00 0.47 0.00 2.84 0.00 0.24 0.00 3.03
DDD per cow per 1,000 days CG 0.00 0.63 0.00 7.64 0.00 0.35 0.00 6.23
SYSute HPCIA IG 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.59 0.00 0.00 0.00 0.00
DDD per cow per 1,000 days CG 0.00 0.00 0.00 2.91 0.00 0.00 0.00 1.64
IUute IG 0.82 2.82 0.00 5.23 0.73 1.67 0.00 5.23 0.67 2.91 0.00 8.27
DDD per cow per 1,000 days CG 0.58 2.75 0.00 7.54 0.51 2.14 0.00 8.89
CALFtot IG 5.25 18.32 0.00 73.23 1.76 14.1 0.00 112.03 0.74 7.09 0.00 64.47
DDD per calf per 1,000 days CG 0.00 8.95 0.00 80.97 0.00 10.56 0.00 71.32
CALF tot HPCIA IG 0.00 1.58 0.00 21.97 0.00 0.00 0.00 38.75 0.00 0.00 0.00 8.24
DDD per calf per 1,000 days CG 0.00 0.00 0.00 6.91 0.00 0.00 0.00 6.79
Other IG 2.18 5.35 0.00 26.12 2.46 4.70 0.00 22.55 2.03 5.21 0.00 25.00
DDD per cow per 1,000 days CG 1.92 4.55 0.00 12.06 1.63 3.94 0.00 13.43
Other HPCIA IG 0.00 0.00 0.00 6.53 0.00 0.00 0.00 6.81 0.00 0.21 0.00 3.39
DDD per cow per 1,000 days CG 0.00 0.00 0.00 4.34 0.00 0.00 0.00 1.81
DDD, defined daily dose; DCD, defined course dose; IG, intervention group; CG, control group; IMMlact, intramammary use during lactation; IMMdry, Intramammary use for dry-off;
SYSudd, Systemic use with indication udder health; SYSute, systemic use with indication uterine health; IUute, intrauterine application; CALFtot, use for calves; HPCIA, Highest priority
critically important antimicrobials; IQR, interquartile range.
and/or herd size resulted in an improvement of the model fit and
were therefore included as fixed effects in the final models.
A statistically significant difference between the TI SYSudd of
CG farms and farms with a chosen udder strategy was observed
with IG using less AMs than CG farms (p = 0.04). Similarly,
a significantly higher TI SYSute was observed in CG farms
compared to IG farms with a chosen uterine strategy (p = 0.02).
Furthermore, in the udder health sector the TI OTH increased
for IG farms with two (p < 0.01) or four (p < 0.01) chosen
udder health strategies, respectively. The choice of one or two
calf health strategies had a significant impact on the TI OTH
HPCIA. The TI OTH HPCIA increased for farms with a chosen
calf health prevention strategy (p = 0.03). On the contrary the
TI OTH HPCIA decreased for farms with two chosen calf health
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TABLE 5 | Estimates (upper line) and P-values (lower line) of the conditional mixed effect regression models investigating the association between treatment incidence
and amount of chosen prevention strategies (Model 1), and between treatment incidence and implementation level of the strategies (Model 2, 1 = implemented,
2 = partially implemented, 3 = not implemented).
TI category MODELS 1: Amount of chosen strategies MODELS 2: Level of implementation
1 2 3 4 5 IFE Implemented Partially implemented Not implemented IFE
EFFECT OF UDDER HEALTH PREVENTION STRATEGIES
IMMlact −0.21 0.03 −0.18 0.16 −0.17 0.07 0.03 −0.04 H*
0.20 0.81 0.28 0.47 0.59 0.37 0.88 0.75 <0.01
IMMlact 2.46 0.04 0.73 3.16 0.70 −0.27 −0.85 0.10 H*
HPCIA 0.11 0.97 0.66 0.14 0.80 0.05* 0.27 0.64 <0.01
IMMdry −0.25 −0.23 −0.14 0.13 −0.14 H* 0.02 −0.51 0.18 H*
0.22 0.14 0.47 0.63 0.72 0.04 0.79 0.03* 0.19 <0.01
SYSudd −0.44 −0.19 −0.15 0.05 0.17 H*,R* 0.04 −0.09 −0.13 H*
0.04* 0.26 0.47 0.87 0.65 <0.03 0.71 0.70 0.51 0.02
SYS udd −1.73 −0.65 1.26 1.42 −0.03 R* 0.10 0.17 −0.87
HPCIA 0.20 0.53 0.33 0.42 0.99 0.01 0.57 0.72 0.03*
OTH −0.22 0.47 0.22 0.78 0.35 R*,H* −0.04 0.18 −0.04 R*
0.25 <0.01* 0.25 <0.01* 0.29 <0.04 0.68 0.42 0.80 <0.01
OTH 2.00 0.64 0.93 2.41 1.44 B*, R* −0.27 −0.26 −0.11 R*
HPCIA 0.16 0.53 0.49 0.17 0.53 <0.04 0.11 0.52 0.76 0.02
EFFECT OF UTERINE HEALTH PREVENTION STRATEGIES
IUute −0.16 0.01 H* −0.23 −0.55 0.44 H*
0.45 0.98 <0.01 0.26 0.23 0.42 <0.01
SYSute −0.56 0.25 H* −0.03 −18.39 −0.15 H*
0.02* 0.55 <0.01 0.89 0.96 0.87 <0.01
SYSute 1.12 −14.02 ◦ 0.39 −23.85 −0.14 ◦
HPCIA 0.70 >0.99 0.91 1.00 >0.99
OTH −0.18 −0.47 R* −0.12 −0.44 −0.46 R*
0.38 0.25 0.03 0.52 0.28 0.48 0.01
OTH 2.28 −4.50 R*, H* −0.14 0.18 −16.06 R*, B*
HPCIA 0.10 0.18 <0.05 0.77 0.96 0.99 <0.01
EFFECT OF CALF HEALTH PREVENTION STRATEGIES
CALFtot −0.26 −0.14 −0.28 0.88 R* 0.01 0.30 −0.34
0.26 0.60 0.28 0.17 0.04 0.97 0.44 0.15
CALFtot 1.03 0.92 0.11 3.09 R* 0.17 −0.33 −0.04 H*
HPCIA 0.37 0.50 0.96 0.29 0.02 0.55 0.64 0.90 0.04
OTH 0.08 0.30 0.30 0.32 R* 0.02 −0.12 −0.47 R*
0.59 0.12 0.26 0.44 <0.01 0.85 0.58 <0.01* 0.01
OTH 2.45 −3.62 2.52 3.90 R* −0.18 0.44 −0.42 R*, B*
HPCIA 0.03* 0.02* 0.19 0.18 <0.02 0.28 0.26 0.15 <0.02
The estimate represents the in- or decrease per 100 units of the respective treatment incidence. (Reference value: models 1: Control farms without intervention, models 2: Farms of the
intervention group without strategy selection in this health sector). Significant additional fixed effects such as herd size, region and/or breed have been included on some models where
they improved the model fit (lowest p-value indicated).
TI, treatment incidence; IMMlact, intramammary use during lactation; IMMdry, Intramammary use for dry-off; SYSudd, Systemic use with indication udder health; SYSute, systemic use
with indication uterine health; IUute, intrauterine application; CALFtot, total use of antimicrobials for replacement calves; OTH, antimicrobial use with other indications; HPCIA, Highest
priority critically important antimicrobials; IFE, included fixed effects; H, herd size; B, breed; R, region.
*Indicates the p-value, which is interpreted as significant (p ≤ 0.05 = significant).
Bold numbers = marked estimate, p-value and additional fixed effect, which are defined as significant.
◦ Inclusion of herdsize, breed and region as additional fixed effect was not possible for these models due to too small sample size in at least one category of each additional fixed effect.
Frontiers in Veterinary Science | www.frontiersin.org 8 January 2021 | Volume 7 | Article 611682
Gerber et al. Antimicrobial Reduction in Dairy Farms
prevention strategies (p = 0.02). In addition, the models that
studying the selection of calf strategies also showed that the
region always had a significant influence on AMU. However,
it was not always the same region that showed the same trend
(increase or decrease).
It was shown that the high implementation level of udder
strategies decreased the consumption of intramammary HPCIAs
(p = 0.05). This is lost with a lower implementation level.
The partial implementation of certain udder strategies had
significantly decreased (p = 0.03) the TI for intramammary dry-
off products. Interestingly, we found that farms with a chosen
udder health strategy, could decrease TI SYSudd HPCIA only, if
the strategies have not been implemented (p = 0.03). Similarly
farms with chosen calf health strategies significantly (p < 0.01)
reduced the AMU in the category OTH, only if the strategies were
not implemented.
Animal Health Data
Animal health indicators of the farms are presented in Table 6.
Neither udder health (YCSCC) (p > 0.05, Kruskal Wallis test)
nor fertility (calving interval, voluntary waiting period, calving
to conception interval) (p > 0.05, Kruskal Wallis test) differed
significantly during the study period. This applies to both the IG
(2017–2019) and the CG (2018–2019).
DISCUSSION
This study investigated the effect of evidence-based prevention
strategies on AMU in three health sectors, udder, uterus and
replacement calves. The hypothesis that farmers which selected
evidence-based management changes for disease prevention
reduce AMU while maintaining animal health compared to
farmers that did not selected management changes, can be
partially accepted. Farmers that had chosen a prevention strategy
in the udder or uterine area are able to significantly reduce the
consumption of systemically applied AMs used for both sectors.
However, there is no significant reduction in AMU in the TI of
intrauterine use or the TI administered for calves. Likewise, the
hypothesis that this AM reduction depends on the level of the
implementation can be partly accepted. For three TI (IMMlact
HPCIA, IMMdry and SYSudd HPCIA) it could be shown that
the implementation level had a significant effect on the reduction
of AMs. However, this effect could not be detected in the uterine
and calf health sectors.
One reason why it was possible to reduce AMU, particularly
systemically applied AMs in dairy cows, is that the number of
acute and severe clinical cases (e.g., acute mastitis, acute metritis)
could be decreased in IG farms, but the occurrence of less severe
cases was not affected by the intervention and therefore the use
of AM for local (intramammary and intrauterine) application
did not change. This is based on the assumption that systemic
AMs are more likely to be applied in severe cases than in mild
cases (61, 62). It is encouraging to note that despite the observed
reduction in systemic AMU, there was no increase in TI in
locally applied preparations. In addition, the IUute, IMMlact,
and IMMdry all show a tendency for a reduction in AMU
when a strategy has been in place on the farm. In our study
we found that the level of prevention strategy implementation
mainly reduced the AMU of critically important antimicrobials.
This confirms findings of a study investigating the impact of
mastitis management on AMU in dairy herds, which shows that
better mastitis management was associated with reduced usage
of critically important AMs (55). Stevens et al. also formulated
the hypothesis that poor management is being masked by the
use of HPCIA (55). Fortunately, it can also be stated that AMU
in the non-HPCIA classes, whilst it had not decreased it had
not increased in any of the three areas. But as Table 5 shows,
“Other HPCIA” is an exception. There, a significant increase in
AMU was observed in connection with the selection of one calf
health prevention strategy. However, it is also evident that there
was a significant decrease in AMU when two strategies were
selected. These two values are difficult to relate to a biologically
plausible explanation. In this context we may have to consider
that many of the farmers also kept veal calves in addition to
the replacement calves and we cannot entirely discriminate if
a treatment was given to a replacement calf or to a veal calf.
However, it is known that purchased calves commingled on a
farm for veal calf production are often more severely affected by
diarrhea and pneumonia than replacement calves (63, 64).
Interestingly, also only partly implemented prevention
strategies showed a significantly positive effect in reducing
intramammary AMU for dry-cow treatment compared to non-
implementation of udder strategies. This suggests that only
certain parts of the prevention strategy are sufficient in terms
of reducing AMU at dry-off; alternatively, this effect was driven
by chance, due to the rather small sample size. Another possible
explanation of seeing an effect of reducing AMU lies in the
definition of partially implemented udder prevention strategies,
which is based on the number of milk SCC analyses. In case
a farmer decided to sample cows with an individual cell count
threshold of higher than 150,000 cells/mL, less samples were
taken than those using the suggested limit of 150,000 cells/mL.
They are therefore categorized as a partially implemented
prevention strategy, and at the same time potentially used less
AM because of the lower chances of detecting subclinical mastitis
cases. These treatments lead to the fact that the TI, in its entirety,
could then not be reduced, although the implementation level
according to the protocol was higher. This possible explanation
shows once again the importance of the veterinarian as a farm
consultant in monitoring and reviewing udder health, to name
but one example (65). If drugs are used for these treatments
without consulting the veterinarian, although this was strictly
not advised in the strategies, farmers may lack the know-how
about which bacteria should be treated at all and at which point
in time the therapy is most successful. Better management is
only one aspect for improving udder health, while quarter level
factors such as pathogen specific risk factors (66) and also cow
breed (17) make a difference. This fact leads to the circumstance
that not all risk factors for a reduced animal health could be
considered and changed by the prevention strategies applied to
the farms and the reduction of AMs may therefore also be lower
than expected. Additionally, it must be taken into account that
a higher SCC threshold might be used to select cows for further
investigation without a deterioration of the udder health at herd
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TABLE 6 | Description of animal health data of the intervention and control group.
Intervention group Control group





















































SCC, somatic cell count; SD, standard deviation.
level. The threshold of 150,000 cells/ml was chosen taking Swiss
legislation into account (67). The described decrease of the TI
SYSudd HPCIA, when farmers have not implemented the chosen
udder health strategy, is probably influenced by other factors than
the proposed prevention strategies. These factors may include
the veterinarian and his or her change of the therapy scheme or
not investigated management changes, which improved animal
health and therefore allowed a reduction of AMU.
AM reduction was not achieved in the replacement calf
sector. This may have various reasons. AMU in replacement
calves is assumed to be overestimated in this study, because
not all calves’ treatments could be clearly allocated to veal or
replacement calves, respectively, due to missing information in
the records. Whenever there was a doubt, a treatment was added
to the replacement calves, except when the treatment explicitly
mentioned that it was for a veal calf. As a result, the known
high AMU in veal calves (68) is at least partially included in
our treatment incidence of the comparatively small number
of replacement calves. Furthermore, the selected management
changes may have been implemented only in the replacement
calves and explicitly not in veal calves that may have been
present in close contact to the replacement calves on the
same farm.
The results on strategy selection and implementation level
allow conclusions why AMs could not be successfully reduced in
all areas. On the one hand, it was found that not all strategies
from one health sector were selected equally frequently. The
fact that not every strategy is equally efficient in promoting
animal health, has also to be considered. It is expected that
if strategies with lower effect have been chosen, the reduction
of AMU also is limited. On the other hand, we know from
a previous questionnaire study in the autumn of 2018 that in
many cases these farmers did not choose prevention strategies
in their problematic area but rather according to their interest
in gaining new knowledge (65). A possible explanation for
this phenomenon is that the expected financial benefit is more
motivating, or perhaps that they were perturbed by the effort
required to solve a problem. Also, the lack of awareness of
having a problem at all would be one possibility why farmers
avoid implementing strategies in areas with existing animal
health issues. Farm-specific and risk-based selection are however
important because the determinants of AM treatment vary
from one farm to another (69). Although a study of Swiss
farmers showed that self-motivated management changes are
better implemented, whether or not these are the most efficient
strategies (70), investing into less problematic areas makes it even
more difficult to reach an effect in AM reduction. Furthermore,
the number of strategies per farm per health sector also varies
substantially (range 1–5 prevention strategies). This fact may
have two consequences. Firstly, we could assume that the more
strategies chosen, the more AMs could be reduced. According
to our data this is not the case. Secondly, it is also possible that
the more strategies chosen, the greater the workload and the
less careful the strategies were implemented, which was most
probably an issue in our study. The systemic use of AMs for udder
health can be taken as an example: with the implementation of
a strategy, the use can be significantly reduced, but the more
strategies chosen, the less the reduction tends to be. In addition to
these explanations, the CG also had the opportunity to improve
their management on their own initiative during the study. This
would also explain the lack of difference in AMU between IG and
CG, and the effect of the strategies themselves is underestimated.
Another possibility why a reduction of AMs could only be
observed in some health sectors is that the treatment strategies of
the various farm veterinarians were very different and therefore
the success of therapy was also very variable. For example, when
AMs are saved for the treatment of acute cases and the alternative
treatment was not successful, AMs saved in these cases must be
used to treat chronic cases. Such a case cannot be ruled out by
this study protocol without prescribed treatment protocols. For
Swiss veterinarians there is a recommendation from the Swiss
government: “Therapy guidelines for the use of antibiotics for
veterinarians” (62). However, following this recommendation is
not compulsory and all preparations approved in Switzerland
may be used. Only the supply of AMs to the farmers for the
application by the farmer itself is regulated (but additionally
depends upon the label of the farm for example for the use
of HPCIA).
Fortunately, there was no significant increase in TI in most
sectors, with the exception of the TI of “Other AMs” of the udder
health section. There, we observed a significant increase of the
TI in farms with two or four strategies implemented, compared
to no strategy implemented. We cannot identify a biologically
meaningful explanation for this, but argue that the prevention
strategies could hardly be the reason for this increase, because we
most probably would have also detected an increase if three or
five strategies are implemented.
The results presented here show that the implementation level
decreased over time. This is an additional plausible explanation
why no more significant reduction of AMs could be produced.
Consistent implementation may fade out since there was no
regular support during the study by veterinarians qualified in
consultation and prevention. Similar findings were reported
from study in Belgium in which worse implementation of
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recommended mastitis management criteria was observed in
farms without veterinary support (55). In the current study,
providing supervision was avoided to be able to investigate
the effect of the strategies without regular support visits and
consultation on the farm. However, for future planning of
AM reduction initiatives, professional support by educated
veterinarians should be considered as an imperative. The
authors suspect that the financial support of the project
participants provided little or no motivation in implementing
the interventions sufficiently in the long term. Despite financial
incentives and financial support for sample analysis, the
implementation level decreased over time. In future projects,
funding should rather be invested for close supervision and
support, than for motivation of farmers. Another possibility
would be to create an incentive system in which financial support
is only provided after the implementation level has been checked.
Previous findings show that both penalty and bonus systems are
motivating for farmers (71). One example of a penalty system in
Europe trying to motivate farmers to decrease AMU is the yellow
card system in Denmark (72). A survey of Swiss farmers and
veterinarians shows that a penalty system (for high AMU) is not
desirable (73).
Within this study, it is not possible to draw conclusions on
the efficiency of the individual strategies, since the sample size
per strategy was too small. Through the continuation of the
here described AM reduction project with a larger cohort, it
may be possible to investigate the effect of single strategies in
the coming years. As described earlier, an adapted management-
changes selection based on a problem analysis, with professional
and regular supervision, would surely be a helpful method of
improving animal health (71). No statement can be made about
the efficiency of individual management strategies, although
different efficiency is expected (74). The two strategies to reduce
the risk of ketosis and to reduce the risk of milk fever occur in
both the uterine and the udder sector. This allows an interaction
of the effect on all TI of these two sectors and there is no
way to quantify the strength of this interaction. However, since
the udder strategies were more often chosen than the uterine
strategies, it can be assumed that reduced AM consumption
in cases of uterine disease on a specific farm may have been
influenced by the selection of udder strategies. Therefore, the
effect of the uterine strategies might have been overestimated in
farms with applications of both, udder and uterine strategies.
Selection bias due to voluntary participation in the study and
an observer bias for the evaluation of the implementation level
is likely to be present in the study. However, these biases are
considered negligible. The selection bias is evenly distributed
across the IG and the CG, because farmers of the CG are
also participating voluntarily. It is possible that particularly
committed, motivated and therefore “good” farmers participated
in the study may have had an influence on the results. It is
possible that the AMU of the participating farms was below
average already before the project started and that the reduction
of AMs could not be as high as it might have been in a
broader study population. However, it must also be mentioned
here that the implementation level is expected to be rather
above average due to the high motivation of the farmers,
and that a reduction of AMs could thus be achieved more
easily. The observer bias is also estimated to be low, since
the standardized assessment sheets used for the evaluation of
the implementation quality are based on objective criteria and the
evaluation was carried out strictly according to detailed scores,
which exclude a subjective evaluation. It is assumed that the level
of implementation on farms was systematically overestimated
based on the classification of how the strategy per health sector
per farm was implemented, even if several strategies were chosen.
However, as this is the case in all the farms analyzed, there is
no overestimation or underestimation among the intervention
farms themselves.
It must also be assumed that the TI for SYSTlact, SYSTute,
CALFtot, and OTHER is slightly underestimated, since not all
long-acting preparations have a separate DDDvet value from
the EMA. This means that the number of days with treatment
is generally underestimated for these categories. This applies to
both IG and CG, so no influence on the comparison of AMU
is expected.
The CG differed significantly from the IG in breed, herd size
and average milk yield. This fact could lead to the consequence
that the reference AMU also differs between the two groups.With
larger herds, the farmer is expected to be more professional and
may therefore have better knowledge of dairy cow management.
However, with a larger herd, it can also be argued that the
number of treatments performed without veterinary consultation
is higher and therefore inadequate or excessive AMU is possible.
In the data set analyzed here, there is no evidence of a distortion
of AMU with respect to herd size. Herds of up to 100 cows
still count as suitable for family farming, therefore no major
management differences in farming are expected between IG and
CG. The larger proportion of dairy cows in the intervention
group and the logically associated higher milk yield could mean a
fundamentally higher AMU in the intervention group, especially
regarding to the AMU as an indication of udder health. A
statistical comparison of the treatment incidence of the first
quarter in 2018 between the two groups showed a statistically
significant difference only in the amount of HPCIAs in systemic
application for udder and uterine health. However, this difference
is interpreted to be negligible for the total AMU, because the total
AMU in these two classes is not statistically significantly different
and therefore only differs in the use of HPCIAs.
CONCLUSIONS
A reduction of AMs in practice using evidence-based strategies
is possible. In our study the TI of systemically administered
AM for udder and uterine health could be reduced for farms
where such a strategy was implemented. Furthermore, it could
be shown that high implementation level of measures to improve
udder health can significantly reduce the use of intramammary
AMs. Maintaining the level of implementation of evidence-
based prevention strategies in practice has been shown to
be challenging. An appropriate evaluation of the value of
financial vs. e.g., human resources should be considered in future
project planning.
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